Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium
2009
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance
2014 Standout
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
2012
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
2009
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Immune Reconstitution Syndrome and Exacerbation of Infections after Pregnancy
2007
Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid
2007
Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps
2006
Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy
2010
Sepsis biomarkers: a review
2010 Standout
Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia
2011
Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach
2009 Standout
Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1–4
2008
Vigilancia de resistencias a los antimicrobianos: estudio VIRA 2006
2006
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
A review of the antimicrobial activity of clavulanate
2003
Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain
2004
Fluoroquinolone resistance among Gram-positive cocci
2002
Irrigation and Debridement in the Management of Prosthetic Joint Infection: Traditional Indications Revisited
2010
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Albumin–drug interaction and its clinical implication
2013 Standout
Pathogenesis and treatment concepts of orthopaedic biofilm infections
2012
In VitroActivity of Ceftibuten at Sub-inhibitory Concentrations in Comparison with Other Antibiotics against Respiratory and Urinary Tract Pathogens
2007
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections
2010
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
2005 Standout
Prosthetic joint infection: diagnosis and management
2011
Variability and Diversity of Nasopharyngeal Microbiota in Children: A Metagenomic Analysis
2011
Significance of Staphylococcus lugdunensis Bacteremia: Report of 28 Cases and Review of the Literature
2008
Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections
2008
Treatment results with debridement and retention of infected hip prostheses
2009
Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: A retrospective, nonrandomized, open-label, historical chart review
2007
Higher Risk of Failure of Methicillin-resistant Staphylococcus aureus Prosthetic Joint Infections
2007
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997
Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention
2010
One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome
2009
Outcome and Predictors of Treatment Failure in Total Hip/Knee Prosthetic Joint Infections Due to Staphylococcus aureus
2011
Novel β-lactam antibiotics and inhibitor combinations
2008
A Superficial Swab Culture is Useful for Microbiologic Diagnosis in Acute Prosthetic Joint Infections
2008
Factors governing the healing of Staphylococcus aureus infections following hip and knee prosthesis implantation: A retrospective study of 95 patients
2011
β-Lactams and β-Lactamase Inhibitors: An Overview
2016 Standout
Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants
2001
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
Two-stage Exchange Arthroplasty for Infected Total Knee Arthroplasty: Predictors of Failure
2011
Early prosthetic joint infections treated with debridement and implant retention
2012
Antimicrobial resistance in
1999
Detection ofStaphylococcus lugdunensisby a new species-specific PCR based on thefblgene
2009
Immunity to fungal infections
2011 Standout
Acute haematogenous prosthetic joint infection: prospective evaluation of medical and surgical management
2010
Clinical Role of ??-Lactam/??-Lactamase Inhibitor Combinations
2003
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
2004 Standout
Optimizing combination rifampin therapy for staphylococcal osteoarticular infections
2013
The human microbiome: at the interface of health and disease
2012 Standout
Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement
2010
Penicillin-binding proteins and β-lactam resistance
2008
Antibiotic resistance and persistence—Implications for human health and treatment perspectives
2020
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Plasma fibronectin as a marker of sepsis
2004
Mechanisms of Antibiotic Resistance
2016 Standout
Combination Treatment of Invasive Fungal Infections
2005
β‐L actam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: A structured review
2012
Diagnosis, management, and prevention of prosthetic joint infections
2013
Long-term outcome of acute prosthetic joint infections due to gram-negative bacilli treated with retention of prosthesis.
2012
Rifampin Combination Therapy for Nonmycobacterial Infections
2010
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Pharmacodynamics of the Antibacterial Effect and Emergence of Resistance to Tomopenem, Formerly RO4908463/CS-023, in an In Vitro Pharmacokinetic Model of Staphylococcus aureus Infection
2008
Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case–control study
2012
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
2014 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Efficacy of Debridement in Hematogenous and Early Post-Surgical Prosthetic Joint Infections
2011
Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis
2009
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Novel Carbapenem Antibiotics for Parenteral and Oral Applications: In Vitro and In Vivo Activities of 2-Aryl Carbapenems and Their Pharmacokinetics in Laboratory Animals
2012
Postantifungal Effects of Echinocandin, Azole, and Polyene Antifungal Agents against Candida albicans and Cryptococcus neoformans
2000
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Three Decades of β-Lactamase Inhibitors
2010 Standout
Staphylococcus Lugdunensis, An Aggressive Coagulase-Negative Pathogen not to be Underestimated
2012
Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia
2005 Standout
Value of Debridement and Irrigation for the Treatment of Peri-Prosthetic Infections. A Systematic Review
2012
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients
2013
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Role of Rifampin against Staphylococcal Biofilm Infections In Vitro , in Animal Models, and in Orthopedic-Device-Related Infections
2018
Microbiological Characteristics, Presumptive Identification, and Antibiotic Susceptibilities of Staphylococcus lugdunensis
2008
Propionibacterium acnes: from Commensal to Opportunistic Biofilm-Associated Implant Pathogen
2014
Polyclonal Population Structure of Streptococcus pneumoniae Isolates in Spain Carrying mef and mef plus erm (B)
2008
Exposure to sub-inhibitory concentrations of gentamicin, ciprofloxacin and cefotaxime induces multidrug resistance and reactive oxygen species generation in meticillin-sensitive Staphylococcus aureus
2017 StandoutNobel
Prosthetic Joint Infection
2014 Standout
Synthesis, characterization, and biomedical assessment of novel bisimidazole–coumarin conjugates
2021 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Relative Fitness of Fluoroquinolone-resistantStreptococcus pneumoniae
2005
Outcome of a Second Two-stage Reimplantation for Periprosthetic Knee Infection
2009
Vigilancia de resistencias a los antimicrobianos: estudio VIRA 2004
2004
Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection
2014
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Outcome of Acute Prosthetic Joint Infections Due to Gram-Negative Bacilli Treated with Open Debridement and Retention of the Prosthesis
2009
Works of J. Prieto being referenced
Decrease in Bacterial Load Versus Resistance Selection of Pneumococcal Subpopulations by β-Lactam Physiological Concentrations over Time: An In Vitro Pharmacodynamic Simulation
2008
Concentraciones plasmáticas de fibronectina como marcador de evolución en pacientes sépticos
2001
Genotypic versus phenotypic characterization, with respect to susceptibility and identification, of 17 clinical isolates of Staphylococcus lugdunensis
2005
Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity againstStreptococcus pneumoniae
1997
Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients
2013
In Vivo and in Vitro Study of Several Pharmacodynamic Effects of Meropenem
1995
Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model
2005
In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives
2007
Conservative Treatment of Staphylococcal Prosthetic Joint Infections in Elderly Patients
2006
Activity of fluconazole: postantifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes
1994
Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation
2008
High Protein Binding and Cidal Activity against Penicillin-Resistant S. pneumoniae: A Cefditoren In Vitro Pharmacodynamic Simulation
2008
Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain
2005
Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain
2006
In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin
2004
β-Lactam Effects on Mixed Cultures of Common Respiratory Isolates as an Approach to Treatment Effects on Nasopharyngeal Bacterial Population Dynamics
2008
Management in the emergency room of patients requiring hospital treatment of community-acquired pneumonia.
2009
Activity of oral antibiotics against respiratory tract pathogens in Spain.
2003
Antibacterial activity of oral antibiotics against community–acquired respiratory pathogens from three European countries
2002
Effects of Antifungal Pretreatment on the Susceptibility of <i>Candida albicans</i> to Human Leukocytes
1997
Streptococcus pneumoniae Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Clonal Diversity and Appearance of Ciprofloxacin-Resistant Epidemic Clones
2001
Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers
1996
In Vitro Activities of Co-Amoxiclav at Concentrations Achieved in Human Serum against the Resistant Subpopulation of HeteroresistantStaphylococcus aureus: a Controlled Study with Vancomycin
1998